Literature DB >> 16137681

A novel 4.1 ezrin radixin moesin (FERM)-containing protein, 'Willin'.

Frank J Gunn-Moore1, Gavin I Welsh, Lissa R Herron, Frances Brannigan, Kanamarlapudi Venkateswarlu, Stewart Gillespie, Margaret Brandwein-Gensler, Rashna Madan, Jeremy M Tavaré, Peter J Brophy, Michael B Prystowsky, Simon Guild.   

Abstract

The 4.1 superfamily of proteins contain a 4.1 Ezrin Radixin Moesin (FERM) domain and are described as linking the cytoskeleton with the plasma membrane. Here, we describe a new FERM domain-containing protein called Willin. Willin has a recognizable FERM domain within its N-terminus and is capable of binding phospholipids. Its intra-cellular distribution can be cytoplasmic or at the plasma membrane where it can co-localize with actin. However, the plasma membrane location of Willin is not influenced by cytochalasin D induced actin disruption but it is induced by the addition of epidermal growth factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137681     DOI: 10.1016/j.febslet.2005.07.097

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Willin and Par3 cooperatively regulate epithelial apical constriction through aPKC-mediated ROCK phosphorylation.

Authors:  Takashi Ishiuchi; Masatoshi Takeichi
Journal:  Nat Cell Biol       Date:  2011-06-19       Impact factor: 28.824

2.  Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells.

Authors:  Yajie Zhang; Ruobing Xu; Guiqin Li; Xiaobin Xie; Jie Long; Hongyan Wang
Journal:  Tumour Biol       Date:  2012-07-11

Review 3.  The Angiomotins--from discovery to function.

Authors:  Susana Moleirinho; William Guerrant; Joseph L Kissil
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

4.  Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis.

Authors:  Xingcheng Chen; Seth Stauffer; Yuanhong Chen; Jixin Dong
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

Review 5.  Willing to Be Involved in Cancer.

Authors:  Frank J Gunn-Moore; Andrew M Tilston-Lünel; Paul A Reynolds
Journal:  Genes (Basel)       Date:  2016-07-18       Impact factor: 4.096

6.  Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway.

Authors:  Ruani N Fernando; Laurent Cotter; Claire Perrin-Tricaud; Jade Berthelot; Sylvain Bartolami; Jorge A Pereira; Sergio Gonzalez; Ueli Suter; Nicolas Tricaud
Journal:  Nat Commun       Date:  2016-07-20       Impact factor: 14.919

7.  FRMD6 has tumor suppressor functions in prostate cancer.

Authors:  Jakob Haldrup; Siri H Strand; Clara Cieza-Borrella; Magnus E Jakobsson; Maria Riedel; Maibritt Norgaard; Stine Hedensted; Frederik Dagnaes-Hansen; Benedicte Parm Ulhoi; Rosalind Eeles; Michael Borre; Jesper V Olsen; Martin Thomsen; Zsofia Kote-Jarai; Karina D Sorensen
Journal:  Oncogene       Date:  2020-11-28       Impact factor: 9.867

8.  Willin, an upstream component of the hippo signaling pathway, orchestrates mammalian peripheral nerve fibroblasts.

Authors:  Susana Moleirinho; Calum Patrick; Andrew M Tilston-Lünel; Jennifer R Higginson; Liselotte Angus; Maciej Antkowiak; Susan C Barnett; Michael B Prystowsky; Paul A Reynolds; Frank J Gunn-Moore
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.

Authors:  Yin Xu; Kaiqiang Wang; Qin Yu
Journal:  Oncotarget       Date:  2016-10-25

10.  FERM domain-containing protein 6 identifies a subpopulation of varicose nerve fibers in different vertebrate species.

Authors:  Josefa Beck; Michael Kressel
Journal:  Cell Tissue Res       Date:  2020-03-21       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.